Research tool patents and the experimental use exemption--a no-win situation?. Nature Biotechnology 17(10): 1027-1028, 1999
Clinical trials in the pharmaceutical industry: The scope of the research exemption under French patent law clarification is still awaited. Journal of Commercial Biotechnology 9(1): 67-71, 2002
Research exemption/experimental use in the European Union: patents do not block the progress of science. Cold Spring Harbor Perspectives in Medicine 5(2): A020941, 2014
Current quality research situation of precious Chinese patent medicine. Zhongguo Zhong Yao Za Zhi 33(3): 329-333, 2008
Integra: The research tool patent revival. Journal of Commercial Biotechnology 10(2): 162-166, 2003
Describing a nursing situation: a management, education and research tool. Soins. Formation Pedagogie Encadrement: Avec la Participation du Ceeiec 1993(5): 47-51, 1993
Trend of Harvesting Situation and Tax Exemption in the Latter Half of 19C the Honam Province. Journal of Rural Development 27(2): 37-53, 2004
Patent Case Puts Price Tag on Research Tool. Genomics and Proteomics 4(1), 2004
PMA primacy: synthesizing the 35 U.S.C. Section 156 patent term extension, 35 U.S.C. Section 271(e)(1) patent infringement exemption as currently applied to medical devices, and medical device preemption jurisprudence to yield a cohesive solution regarding scope of coverage. Food and Drug Law Journal 56(3): 339-349, 2001
Brazil takes a step towards patent exemption for HIV drugs. Lancet. Infectious Diseases 5(7): 399, 2005
Judgment regarding exemption from punishment in the violation of traffic laws in an urgent situation. Yngre Laeger 13(23): 209-210, 1967
Patent office search files: a tool for historical research and technological development. Science 137(3531): 673-674, 1962
A patent strategy for genomic and research tool patents: are there any differences between the USA, Europe and Japan?. Drug Discovery Today 5(12): 554-559, 2000
Patent Office Search Files: A Tool for Historical Research and Technological Development. Science 137(3531): 672-673, 1962
The puzzling situation of hospital exemption for advanced therapy medicinal products in Europe and stakeholders' concerns. CytoTherapy 16(12): 1597-1600, 2014